市場調査レポート
商品コード
1497880
経腸栄養製剤市場:製品、カテゴリー、用途、流通チャネル、エンドユーザー別-2024-2030年世界予測Enteral Feeding Formulas Market by Product (Disease-Specific Formulas, Standard Formulas), Category (Adult Formula, Pediatric Formula), Application, Distribution Channel, End-Users - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
経腸栄養製剤市場:製品、カテゴリー、用途、流通チャネル、エンドユーザー別-2024-2030年世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
|
経腸栄養製剤市場規模は、2023年に61億米ドルと推定され、2024年には65億9,000万米ドルに達し、CAGR 8.11%で2030年には105億4,000万米ドルに達すると予測されています。
経腸栄養製剤は、経口摂取はできないが消化管は機能している人のためにデザインされた食事療法です。これらの製剤はチューブを通して胃や腸に直接供給され、完全栄養または補助栄養を提供するように処方されます。このような専門的な栄養補給は、重篤な疾患、嚥下障害、消化管機能障害を有する患者、または手術後の回復期にある患者にとって極めて重要であり、健康の改善または維持に必要な栄養素を確実に摂取することができます。慢性疾患や疾病に罹患しやすい高齢者人口の世界の増加により、経腸栄養製剤の必要性が高まっています。回復プロセスを強化し、入院期間を短縮する役割を含む経腸栄養の利点に関するヘルスケアプロバイダーや患者の意識の高まりが、経腸栄養製剤市場の成長を促進しています。特定の状態における非経口栄養への嗜好の高まりが市場の成長を阻害しています。経腸栄養製品をより安全で効率的にする製剤と送達システムの継続的な改良が、経腸栄養製剤の成長機会を生み出しています。
主な市場の統計 | |
---|---|
基準年[2023] | 61億米ドル |
予測年 [2024] | 65億9,000万米ドル |
予測年 [2030] | 105億4,000万米ドル |
CAGR(%) | 8.11% |
地域別洞察
南北アメリカでは、高度なヘルスケアインフラ、慢性疾患の高い有病率、高齢化人口の増加により、経腸栄養市場が非常に発展しており、これらすべてが経腸栄養ソリューションの使用を必要としています。さらに、同地域では技術的に先進的な製品の採用が顕著であり、経腸栄養の高品質基準を保証する厳格なガイドラインがあるため、市場の成長がさらに促進されます。APAC地域は、経腸栄養の利点に関する意識の高まり、ヘルスケア支出の増加、地域全体のヘルスケア施設の改善により、経腸栄養製剤市場の急速な成長を目の当たりにしています。人口が多い中国やインドを含む国々では、慢性疾患や栄養不良に苦しむ患者数が急増しており、経腸栄養製剤の必要性を高めています。EMEA地域は多様な市場情勢を示しています。欧州は、確立されたヘルスケアシステム、慢性疾患の高い有病率、大手経腸栄養剤メーカーの強い存在感により、同地域をリードしています。中東・アフリカ市場は、ヘルスケアインフラへの投資の増加と臨床栄養に対する意識の高まりにより、成長の可能性を示しています。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは、経腸栄養製剤市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、経腸栄養製剤市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、経腸栄養製剤市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[187 Pages Report] The Enteral Feeding Formulas Market size was estimated at USD 6.10 billion in 2023 and expected to reach USD 6.59 billion in 2024, at a CAGR 8.11% to reach USD 10.54 billion by 2030.
Enteral feeding formulas are dietary solutions designed for individuals who are unable to consume food orally but have a functioning digestive tract. These formulas are delivered through tubes directly into the stomach or intestine and are formulated to provide complete or supplemental nutrition. This specialized nutrition support is critical for patients who are critically ill, have swallowing difficulties, or gastrointestinal dysfunction, or are recovering from surgery, ensuring they receive the necessary nutrients to improve or maintain their health. The global increase in the elderly population who are prone to chronic conditions and diseases is necesistating the need for enteral feeding formulas. Growing awareness among healthcare providers and patients about the benefits of enteral nutrition, including its role in enhancing the recovery process and reducing hospital stays is driving the growth of the enteral feeding formulas market. Growing preference for parenteral nutrition in certain conditions hampers the growth of the market. Ongoing improvements in the formulation and delivery systems of enteral feeding products that make them safer and more efficient are creating opportunities for the growth of enteral feeding formulas.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.10 billion |
Estimated Year [2024] | USD 6.59 billion |
Forecast Year [2030] | USD 10.54 billion |
CAGR (%) | 8.11% |
Regional Insights
In the Americas, the market for eternal feeding is highly developing due to its advanced healthcare infrastructure, high prevalence of chronic diseases, and growing aging population, all of which necessitate the use of enteral feeding solutions. Additionally, the region observes a significant adoption of technologically advanced products and has stringent guidelines ensuring high-quality standards for enteral nutrition, further driving the market growth. The APAC region is witnessing rapid growth in the enteral feeding formulas market, attributed to the rising awareness about the benefits of enteral nutrition, increasing healthcare spending, and improvements in healthcare facilities across the region. Countries including China and India, with their large populations, are seeing a surge in the number of patients suffering from chronic conditions and malnutrition, which boosts the need for enteral feeding formulas. The EMEA region exhibits a diverse market landscape. Europe leads in the region due to its well-established healthcare systems, high prevalence of chronic diseases, and strong presence of leading enteral formula manufacturers. The market in the Middle East and Africa shows potential for growth due to increasing investments in healthcare infrastructure and growing awareness about clinical nutrition.
Market Insights
The market dynamics represent an ever-changing landscape of the Enteral Feeding Formulas Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Enteral Feeding Formulas Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Enteral Feeding Formulas Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Vygon Introduces Innovative Nutrisafe2 Feeding System for Enhanced Neonatal Care
Vygon launched the Nutrisafe2 feeding system, specifically engineered to meet the delicate nutritional needs of neonates. This advanced system is designed to offer a safer, more accurate method of enteral feeding for newborns, addressing the critical importance of nutrition during the early stages of life. The Nutrisafe2 system is distinguished by its unique safety features that minimize the risks associated with enteral feeding practices, such as misconnections and the inadvertent delivery of incorrect nutritional doses. [Published On: 2024-03-18]
Kate Farms Introduces Whole Food-Based Enteral Feeding Solutions
Kate Farms introduced whole-food blended meals specifically designed for enteral feeding, presented in user-friendly, resealable pouches. This development is noteworthy as these pouches are engineered to seamlessly connect with commonly used tube feeding devices, promoting ease of use. The product line epitomizes a blend of nutritional science and convenience, catering to the essential dietary needs of individuals dependent on tube feeding for sustenance. [Published On: 2023-11-01]
Nestle Health Science Invests USD 43 Million in Advanced Enteral Feeding Formula Facility
Nestle Health Science is significantly enhancing its manufacturing capabilities in Eau Claire, Wisconsin, through a substantial USD 43 million investment. This strategic financial infusion aims to expand and upgrade the facility's operations, particularly focusing on producing enteral feeding formulas. These specialized nutritional solutions are essential in medical settings, providing vital nourishment for patients unable to consume food orally. [Published On: 2023-01-18]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Enteral Feeding Formulas Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Enteral Feeding Formulas Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Ltd, B. Braun SE, Danone S.A., Fresenius Kabi AG, Global Health Products, Inc., Hormel Foods Corporation, Johnson & Johnson Services, Inc, Kate Farms, Inc., Medline Industries, Inc., Medtrition, Inc., Meiji Holdings Co., Ltd, Nestle SA, Nutricia North America, Otsuka Holdings Co., Ltd, Primus Pharmaceuticals, Inc., Real Food Blends by Nutrica, Reckitt Benckiser Group plc., and Victus, Inc..
Market Segmentation & Coverage